Form 4 for CRVL CORVEL CORP
Accepted 2023-12-08 00:00:00 ET · period of report 2023-12-06 · accession 0001754499-23-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-08 | 2023-12-06 | CRVL | O'Brien Brandon | CFO | F - Tax | $221.10 | -728 | 5,262 | -12% | -$161.0K |
| DM | 2023-12-08 | 2023-12-06 | CRVL | O'Brien Brandon | CFO | M - OptEx | $78.00 | +1,084 | 5,275 | +26% | +$84.6K |
| DM | 2023-12-08 | 2023-12-06 | CRVL | O'Brien Brandon | CFO | M - OptEx | $221.10 | -1,084 | 0 | -100% | -$239.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-06 | F | D | 321 | $221.10 | 5,589 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-06 | F | D | 352 | $221.10 | 5,910 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-06 | M | A | 1,000 | $77.93 | 6,262 | D | — | — | |
| 4 | Common | Common Stock | 2023-12-06 | F | D | 16 | $221.10 | 5,274 | D | — | — | |
| 5 | Common | Common Stock | 2023-12-06 | M | A | 42 | $87.49 | 5,290 | D | — | — | |
| 6 | Common | Common Stock | 2023-12-06 | F | D | 14 | $221.10 | 5,248 | D | — | — | |
| 7 | Common | Common Stock | 2023-12-06 | F | D | 13 | $221.10 | 5,262 | D | — | — | |
| 8 | Common | Common Stock | 2023-12-06 | M | A | 42 | $70.24 | 5,275 | D | — | — | |
| 9 | Common | Common Stock | 2023-12-06 | F | D | 12 | $221.10 | 5,262 | D | — | — | |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-06 | M | D | 1,000 | $221.10 | 1,332 | D | $77.93 · — to 2024-11-05 | 1,000 Common Stock | (F3) Option will vest based on achievement of certain performance criteria relating to earnings growth. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-06 | M | D | 42 | $221.10 | 0 | D | $87.49 · — to 2024-08-08 | 42 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-06 | M | D | 42 | $221.10 | 0 | D | $70.24 · — to 2024-04-25 | 42 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |